LUTEINISING UNRUPTURED FOLLICLE SYNDROME

This adverse event was reported 5 times

LUTEINISING UNRUPTURED FOLLICLE SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHORIONIC GONADOTROPIN 1 0.0018
1 CHORIOGONADOTROPIN ALFA 1 0.0004
2 NAPROXEN SODIUM 220MG 1 0.0001
3 LEUPROLIDE ACETATE 1 0.0000
4 LEFLUNOMIDE 1 0.0000
5 NAPROXEN SODIUM 1 0.0000
6 METHOTREXATE SODIUM 1 0.0000
7 ETANERCEPT 1 0.0000
See all drugs enriched for association with LUTEINISING UNRUPTURED FOLLICLE SYNDROME

LUTEINISING UNRUPTURED FOLLICLE SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 1 0.0000
1 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
2 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
3 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with LUTEINISING UNRUPTURED FOLLICLE SYNDROME